Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 1 44Phase 3 10Phase 1/2 6Phase NA 4Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 2Neoplasms 1Clear-cell metastatic renal cell carcinoma 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × pazopanib × Clear all
NCT02555748 2026-03-31

SUP-R

Institut Claudius Regaud

Phase 4 Completed
47 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01521715 2017-08-23

FLIPPER

iOMEDICO AG

Phase 4 Completed
44 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01205230 2012-05-22

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK

GlaxoSmithKline

Phase 4 Completed
34 enrolled 17 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡